Skip to main content
Log in

Effect of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Randomized, Multicenter Trial (EPICC Study)

  • ORIGINAL ARTICLE
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Introduction and Objectives

Pulmonary congestion (PC) is associated with an increased risk of hospitalization and death in patients with heart failure (HF). Lung ultrasound has shown to be highly sensitive for detecting PC in HF. The aim of this study is to evaluate whether lung ultrasound–guided therapy improves 6-month outcomes in patients with HF compared with conventional treatment.

Materials and Methods

Randomized, multicenter, single-blind clinical trial in patients discharged from Internal Medicine Departments after hospitalization for decompensated HF. Participants will be assigned 1:1 to receive treatment guided according to the presence of lung ultrasound signs of congestion (semi-quantitative evaluation of B lines and the presence of pleural effusion) versus clinical assessment of congestion. The primary outcome is the combination of cardiovascular death and readmission for HF at 6 months.

Conclusions

The results of this study will provide more evidence about the impact of lung ultrasound on treatment monitoring in patients with chronic HF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Fonarrow GC, Heywood JT, Heindenreich PA, et al. Temporal trends in clinical characteristics, treatments and outcomes for heart failure hospitalizations. 2002 to 2004: findings from acute decomensated heart failure national registry (ADHERE). Am Heart J. 2007;153:1021–8.

    Article  Google Scholar 

  2. O’Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalizae with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008;156:662–73.

    Article  PubMed  Google Scholar 

  3. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119(Suppl 1):S3–10.

    Article  PubMed  Google Scholar 

  4. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of theEuropean Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423–33.

    Article  PubMed  Google Scholar 

  5. Dunlap ME, Sobotka PA. Fluid re-distribution rather than accumulation causes most cases of decompensated heart failure. J Am Coll Cardiol. 2013;62:165–6.

    Article  PubMed  Google Scholar 

  6. Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload inacute heart failure—re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10:165–9.

    Article  PubMed  Google Scholar 

  7. Peacock WF, Soto KM. Current techniques of fluid status assessment. Contrib Nephrol. 2010;164:128–42.

    Article  PubMed  Google Scholar 

  8. Di Somma S, Navarin S, Giordano S, Spadini F, Lippi G, Cervellin G, et al. The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure. Clin Chem Lab Med. 2012;50:2093–105.

    Article  CAS  PubMed  Google Scholar 

  9. Platz E, Lewis EF, Uno H, et al. Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J. 2016;36:1244–51.

    Article  Google Scholar 

  10. Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, et al. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur Heart J. 2015;17:1172–81.

    Article  Google Scholar 

  11. Coiro S, Porot G, Rossignol P, et al. Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalitation: a two-centre cohort study. Sci Rep. 2016;6:394.

    Article  CAS  Google Scholar 

  12. Trezzi M, Torzillo D, Ceriani E. Lung ultrasonography for the assessment of rapid extravascular water variation: evidence from hemodialysis patients. Intern Emerg Med. 2013;8:409–15.

    Article  PubMed  Google Scholar 

  13. Cortellaro F, Ceriani E, Spinelli M, Campanella C, Bossi I, Coen D, et al. Lung ultrasound for monitoring cardiogenic pulmonary edema. Intern Emerg Med. 2017;12(7):1011–7.

    Article  PubMed  Google Scholar 

  14. Gustafsson M, Alehagen U, Johansson P. Imaging congestion with a pocket ultrasound device: prognostic implications in patients with chronic heart failure. J Card Fail. 2015;21:548–54.

    Article  PubMed  Google Scholar 

  15. Aras MA, Teerlink JR. Lung ultrasound: a “B-line” to the prediction of decompensated heart failure. Eur Heart J. 2016;14:1252–4.

    Article  Google Scholar 

  16. Picano E, Pellikka PA. Ultrasound of extravascular lung water: a new standard for pulmonary congestion. Eur Heart J. 2016;37:2097–14.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gundersen GH, Norekval TM, Graven T, et al. Patient-reported outcomes and associations with pleural effusion in outpatients with heart failure: an observational cohort study. BMJ Open. 2017;7:e013734.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Öhman J, Harjola VP, Karjalainen P, Lassus J. Focused echocardiography and lung ultrasound protocol for guiding treatment in acute heart failure. ESC Heart Fail. 2018;5(1):120–8.

    Article  PubMed  Google Scholar 

  19. Miglioranza MH, Picano E, Badano LP, Sant’Anna R, Rover M, Zaffaroni F, et al. Pulmonary congestion evaluated by lung ultrasound predicts decompensation in heart failure outpatients. Int J Cardiol. 2017;240:271–8.

    Article  PubMed  Google Scholar 

  20. Dickstein K, Cohen-Solal A, Filippatos G, JJ MM, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.

    Article  CAS  PubMed  Google Scholar 

  21. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.

    Article  CAS  PubMed  Google Scholar 

  22. Pellicori P, Shah P, Cuthbert J, Urbinati A, Zhang J, Kallvikbacka-Bennett A, et al. Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. Eur J Heart Fail. 2019.

  23. Pivetta E, Goffi A, Nazerian P, Castagno D, Tozzetti C, Tizzani P, et al. Lung ultrasound integrated with clinical assessment for the diagnosis of acute decompensated heart failure in the emergency department: a randomized controlled trial. Eur J Heart Fail. 2019.

  24. Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparision with natriuretic peptides. Eur J Heart Fail. 2008;10:70–7.

    Article  CAS  PubMed  Google Scholar 

  25. Rivas-Lasarte M, Maestro-Benedicto A, Fernandez-Martinez J, Alvarez-García J, Gonzalez E, Lopez-Lopez L, et al. Lung ultrasound may reduce heart failure hospitalizations: preliminary results from the LUS-HF Trial. J Heart Lung Transplant. 2019;38(4, Supplement):S141.

    Article  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the Spanish National Society of Internal Medicine for supporting this study as well as the working groups for Heart Failure and Clinical Ultrasound. Thanks also go to Dr. Juan Ignacio Pérez-Calvo and Dr. Juan José Granizo for their methodological help.

Funding

This study was partially supported by grants from the Instituto de Salud Carlos III supported with funds from the Spanish Ministry of Health and FEDER (PI15/00773, and PI18/00456).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Manuel Méndez Bailón.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All the procedures involving human participants performed in this study are in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bailón, M.M., Rodrigo, J.M.C., Lorenzo-Villalba, N. et al. Effect of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Randomized, Multicenter Trial (EPICC Study). Cardiovasc Drugs Ther 33, 453–459 (2019). https://doi.org/10.1007/s10557-019-06891-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-019-06891-z

Keywords

Navigation